Treatment of type 2 diabetes

Prescrire International

Volumn 12, Issue 63, 2003, Pages 28-30

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; CHLORPROPAMIDE; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; MIGLITOL; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC FOOT; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; FOOT AMPUTATION; HEALTH CARE QUALITY; HUMAN; HYPERGLYCEMIA; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MONOTHERAPY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED KINGDOM; ARTICLE; DRUG COMBINATION;

CLINICAL TRIALS; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; GLYBURIDE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; RANDOMIZED CONTROLLED TRIALS;

EID: 0037313513     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Prescrire Editorial Staff "Managing type 2 diabetes" Prescr Int 2001; 10 (55): 158.
2. UK Prospective Diabetes Study (UKPDS) ▶ ▶ ▶ Group "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)" Lancet 1998; 352: 837-853.
3. UK Prospective Diabetes Study (UKPDS) Group "Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)" Lancet 1998; 352: 854-865.
4. Turner RC et al. "Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49)" JAMA 1999; 281 (21): 2005-2012.
5. Prescrire Rédaction "Arrêts de commercialisation: Diabinèse°" Rev Prescr 1998; 18 (182): 199.
6. "The UK Prospective Diabetes Study" (letters) Lancet 1998; 352: 1932-1934.
7. Flemmer MC and Vinik AI "Evidence-based therapy for type 2 diabetes" Postgrad Med 2000; 107 (5): 27-47.
8. Shichiri M et al. "Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients" Diabetes Care 2000; 23 (suppl. 2): 21-29.
9. French agency for health accreditation and evaluation "Stratégie de prise en charge du patient diabétique de type 2 à l'exclusion de la prise en charge des complications" March 2000: 161 pages.
10. American Diabetes Association "Implications of the United Kingdom Prospective Diabetes Study" Diabetes Care 2002; 25 (suppl. 1): 28-32.
11. Veterans Health Administration "Clinical practice guideline for the management of diabetes mellitus in the primary care setting" Version 2.2, December 1999: 185 pages. Available on the Internet: http://www.va.gov/health/diabetes. (module G, pages 32-33).
12. Institute for Clinical Systems Improvement "Management of type 2 diabetes mellitus". Octobre 2001: 62 pages.
13. Meltzer S et al. "Lignes directrices de pratique clinique 1998 pour le traitement du diabète au Canada" CMAJ 1998; 159 (8, suppl.):1-31. Updated in: Gerstein HC et al. "CDA position statement regarding the UKPDS and revision of diabetes clinical practice guidelines accounting for the UKPDS results". Website: http://www.diabetes.ca consulted on 5 August 2002.
14. French agency for health product safety "Recommandations pour le traitement médicamenteux du diabète de type 2 (I) " Press Med 1999; 28 (28): 1527-1533.
15. Prescrire Editorial Staff "What use are oral antidiabetic drugs?" Prescr Int 1996; 5 (26): 186-190.
16. Boissel JP "Le mauvais roman de l'UGDP" Rev Prescr 1996; 16 (164): 548-549.
17. UK Prospective Diabetes Study Group "UK Prospective Diabetes Study (UKPDS) VIII. Study design, progress and performance" Diabetologia 1991; 34: 877-890.
18. Olsson J et al. "Increased mortality in type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study" Diabetologia 2000; 43: 558-560.
19. Johnson JA et al. "Decreased mortality associated with the use of metformin compared to sulfonylurea monotherapy in type 2 diabetes" Diabetologia 2001; 44 (suppl. 1) (abstr. 429): 112.
20. Fisman EZ et al. "Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up" Clin Cardiol 2001; 24: 151-158.